Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion
www.fda.gov/Drugs/DrugSafety/ucm459579.htm
Common adverse reactions include gastrointestinal symptoms (which may lead to intestinal obstruction in severe cases), headache, migraine, dehydration, and erectile dysfunction
Key facts about GLP-1-related gastroparesis: How it happens: GLP-1 drugs slow gastric emptying as part of their mechanism, but this effect becomes excessive in some people Whos at risk: Those with pre-existing digestive disorders, prior gastric surgery, long-standing diabetes, or elderly patients face higher risk Timeline: Symptoms can appear at any point during treatment, especially during dose increases Reversibility: Most cases improve after dose reduction or medication discontinuation, with recovery taking days to several months Management options: Dietary changes (smaller, low-fat meals), slower dose escalation, supportive medications, or temporary drug cessation Seek immediate medical attention for severe vomiting, dehydration signs, intense abdominal pain, or blood in vomit or stool
